GL1X · GenesisL1 explorer

Research workbench

Structure of human mcl-1 in complex with thienopyrimidine inhibitor

Analyse Structure of human mcl-1 in complex with thienopyrimidine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6QGD
Type
protein
Length
512 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Maltose-binding periplasmic PROTEIN,INDUCED myeloid leukemia cell differentiation protein…
UniProt
P0AEY0, Q07820
Ligands
J1N, GLC, NA
Pockets
7 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 56% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMaltose-binding periplasmic PROTEIN,INDUCED myeloid leukemia cell differentiation protein mcl-1protein51256% helix, 14% strandP0AEY0, Q07820

Ligands and binding sites

  • J1N · 2-[(6-ethyl-5-phenyl-thieno[2,3-d]pyrimidin-4-yl) amino]-3-oxidanyl-propanoic acid · ligand · chains A
  • GLC · alpha-D-glucopyranose · sugar · 2 copies · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12860.710.8531GLC, NA
23360.560.7632empty
3940.480.8114J1N
4650.400.7916empty
5860.390.7819empty

Compared structures

  • 6QGD · Structure of human Mcl-1 in complex with thienopyrimidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.